219 related articles for article (PubMed ID: 16802351)
1. The heritable determinants of cartilage oligomeric matrix protein.
Williams FM; Andrew T; Saxne T; Heinegard D; Spector TD; MacGregor AJ
Arthritis Rheum; 2006 Jul; 54(7):2147-51. PubMed ID: 16802351
[TBL] [Abstract][Full Text] [Related]
2. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project.
Clark AG; Jordan JM; Vilim V; Renner JB; Dragomir AD; Luta G; Kraus VB
Arthritis Rheum; 1999 Nov; 42(11):2356-64. PubMed ID: 10555031
[TBL] [Abstract][Full Text] [Related]
3. Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation.
Fernandes FA; Pucinelli ML; da Silva NP; Feldman D
Scand J Rheumatol; 2007; 36(3):211-5. PubMed ID: 17657676
[TBL] [Abstract][Full Text] [Related]
4. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.
Vilím V; Vytásek R; Olejárová M; Machácek S; Gatterová J; Procházka B; Kraus VB; Pavelka K
Osteoarthritis Cartilage; 2001 Oct; 9(7):612-8. PubMed ID: 11597173
[TBL] [Abstract][Full Text] [Related]
5. Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication.
Wisłowska M; Jabłońska B
Rheumatol Int; 2005 Jun; 25(5):373-8. PubMed ID: 15739097
[TBL] [Abstract][Full Text] [Related]
6. Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker.
Verma P; Dalal K
J Orthop Res; 2013 Jul; 31(7):999-1006. PubMed ID: 23423905
[TBL] [Abstract][Full Text] [Related]
7. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
Wisłowska M; Jabłońska B
Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
[TBL] [Abstract][Full Text] [Related]
8. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
[TBL] [Abstract][Full Text] [Related]
9. A relationship between mechanically-induced changes in serum cartilage oligomeric matrix protein (COMP) and changes in cartilage thickness after 5 years.
Erhart-Hledik JC; Favre J; Asay JL; Smith RL; Giori NJ; Mündermann A; Andriacchi TP
Osteoarthritis Cartilage; 2012 Nov; 20(11):1309-15. PubMed ID: 22868052
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis.
Andersson ML; Thorstensson CA; Roos EM; Petersson IF; Heinegård D; Saxne T
BMC Musculoskelet Disord; 2006 Dec; 7():98. PubMed ID: 17156423
[TBL] [Abstract][Full Text] [Related]
11. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
Sharif M; Kirwan JR; Elson CJ; Granell R; Clarke S
Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
[TBL] [Abstract][Full Text] [Related]
12. Association of higher levels of serum cartilage oligomeric matrix protein and N-telopeptide crosslinks with the development of radiographic hip osteoarthritis in elderly women.
Kelman A; Lui L; Yao W; Krumme A; Nevitt M; Lane NE
Arthritis Rheum; 2006 Jan; 54(1):236-43. PubMed ID: 16385523
[TBL] [Abstract][Full Text] [Related]
13. Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis.
Petersson IF; Boegård T; Dahlström J; Svensson B; Heinegård D; Saxne T
Osteoarthritis Cartilage; 1998 Jan; 6(1):33-9. PubMed ID: 9616437
[TBL] [Abstract][Full Text] [Related]
14. Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project.
Jordan JM; Luta G; Stabler T; Renner JB; Dragomir AD; Vilim V; Hochberg MC; Helmick CG; Kraus VB
Arthritis Rheum; 2003 Mar; 48(3):675-81. PubMed ID: 12632420
[TBL] [Abstract][Full Text] [Related]
15. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.
Senolt L; Braun M; Olejárová M; Forejtová S; Gatterová J; Pavelka K
Ann Rheum Dis; 2005 Jun; 64(6):886-90. PubMed ID: 15897309
[TBL] [Abstract][Full Text] [Related]
16. [Serum levels of cartilage oligomeric matrix protein in the diagnosis of knee osteoarthritis].
Li H; Wang D; Wu ZQ; Zhong JM; Yuan YJ
Zhongguo Gu Shang; 2012 May; 25(5):380-3. PubMed ID: 22870681
[TBL] [Abstract][Full Text] [Related]
17. Serum cartilage oligomeric matrix protein and other biomarker profiles in tibiofemoral and patellofemoral osteoarthritis of the knee.
Sharif M; Granell R; Johansen J; Clarke S; Elson C; Kirwan JR
Rheumatology (Oxford); 2006 May; 45(5):522-6. PubMed ID: 16319098
[TBL] [Abstract][Full Text] [Related]
18. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint.
Sharif M; Saxne T; Shepstone L; Kirwan JR; Elson CJ; Heinegård D; Dieppe PA
Br J Rheumatol; 1995 Apr; 34(4):306-10. PubMed ID: 7788143
[TBL] [Abstract][Full Text] [Related]
19. Persistent high serum levels of cartilage oligomeric matrix protein in a subgroup of patients with traumatic knee injury.
Kühne SA; Neidhart M; Everson MP; Häntzschel H; Fine PR; Gay S; Häuselmann HJ; Gay RE
Rheumatol Int; 1998; 18(1):21-5. PubMed ID: 9672995
[TBL] [Abstract][Full Text] [Related]
20. Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology.
Dragomir AD; Kraus VB; Renner JB; Luta G; Clark A; Vilim V; Hochberg MC; Helmick CG; Jordan JM
Osteoarthritis Cartilage; 2002 Sep; 10(9):687-91. PubMed ID: 12202121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
